Skip to main content

Table 1 SLE patients and healthy controls characteristics

From: Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients

  SLE patients Healthy controls P-value
n 103 114 -
Age, years 44.9 ± 14.1 47.4 ± 13.5 0.182
BMI, Kg/m2 26.6 ± 4.9 26.8 ± 4.9 0.689
Current smokers, n (%) 14 (15.6%) 23 (22.1%) 0.246
Alcohol intake, n (%) 4 (3.9%) 4 (3.6%) 0.602
Postmenopausal, n (%) 44 (49.4%) 57 (53.3%) 0.593
Arterial hypertension, n (%) 52 (50.5%) 47 (42.7%) 0.257
Hyperlipidemia, n (%) 66 (64.1%) 66 (60.6%) 0.596
Diabetes mellitus, n (%) 5 (4.9%) 8 (7.2%) 0.472
  1. Values represent mean ± standard deviation or frequencies of the individuals that presented the characteristic. Differences were assessed using T-test for continuous variables or χ2 or Fisher's exact test for proportions.
  2. BMI, body mass index; SLE, Systemic Lupus Erythematosus